Business
NuGen Medical Appoints Louise Cresswell as Commercial Lead - United Kingdom
Toronto, Ontario--(Newsfile Corp. - April 3, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the...
About this update from Nugen Medical Devices Inc
[{"type":"text","content":"NuGen Medical Appoints Louise Cresswell as Commercial Lead - United KingdomToronto, Ontario--(Newsfile Corp. - April 3, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the \"Company\" or \"NuGen\") is pleased to announce the appointment of Louise Cresswell as the Commercial Lead for the United Kingdom. Ms. Cresswell has an extensive background working in the UK health sector both as a registered nurse and in commercial, sales and marketing roles with international manufacturers and suppliers of medical technologies. As Commercial Lead, Ms. Cresswell will be responsible for growth of NuGen's InsuJet™ needle-free injection device for insulin administration in the UK market, leading commercial activities and accelerating growth to the National Health Services (the \"NHS\") and private hospitals by positioning the Company's Medical Devices as the supplier of choice with distribution partners, clinicians and patients.InsuJet™ looks to become listed on the NHS' Drug Tariff making it available free of charge to all diabetic patients with an NHS prescription for insulin, which means InsuJet™ can be prescribed for safe medication delivery. The payment of the InsuJet™ device will be to NuGen through the NHS Drug Tariff payment mechanism or direct from hospital buyers.\"Louise's engagement with clinical and non-clinical influencers as well as various decision makers within in the NHS will position InsuJet™ and NuGen to supply a needle-free insulin delivery option opening a very large market for us,\" commented Richard Buzbuzian, CEO. \"Once listed on the NHS Drug Tariff, InsuJet™ will be free of charge to those in the United Kingdom via a prescription providing access to improved care for millions of diabetics.\"\"InsuJet™ contributes to improving the long-term management of diabetic patients, by offering a needle-free injection device for the administration of insulin. This is an exciting time for me to join the NuGen team and to help in making a difference to patient care,\" commented Louise Cresswell.Efficacy of InsuJet™ showing improved insulin uptake of upwards of 40% can be found on the Company's website: https://www.insujet.com/.Clinical Studies, Certificates and ReportsFor more information regarding clinical studies, certificates, or InsuJet™ reports, please visit www....